Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Metabolic Brain Disease|April 28, 2021
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunitySusan J van Rensburg, Ronald van Toorn, Rajiv T Erasmus, et al.
Diabetes Research and Clinical Practice|February 3, 2016
Genetic risk of type 2 diabetes in populations of the African continent: A systematic review and meta-analysesYandiswa Y Yako, Magellan Guewo-Fokeng, Eric V Balti, et al.
Scientific Reports|March 9, 2022
Expression of whole blood miR-126-3p, -30a-5p, -1299, -182-5p and -30e-3p in chronic kidney disease in a South African community-based sampleDipuo D Motshwari, Cindy George, Don M Matshazi, et al.
Expert Review of Molecular Diagnostics|April 15, 2023
Pathology-supported genetic testing for the application of breast cancer pharmacodiagnostics: family counselling, lifestyle adjustments and change of medicationAbisola O Okunola, Karin J Baatjes, Annalise E Zemlin, et al.
Metabolic Brain Disease|February 18, 2014
The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factorsWiliam Davis, Susan J van Rensburg, Frans J Cronje, et al.
Clinical Chemistry and Laboratory Medicine|June 2, 2023
Point-of-care testing performed by healthcare professionals outside the hospital setting: consensus based recommendations from the IFCC Committee on Point-of-Care Testing (IFCC C-POCT)Adil I Khan, Busadee Pratumvinit, Ellis Jacobs, et al.
IJID Regions|June 26, 2023
An investigation of the correlation of vitamin D status and management outcomes in patients with severe COVID-19 at a South African tertiary hospitalThumeka P Jalavu, Lovemore N Sigwadhi, Maritha J Kotze, et al.
Annals of Clinical Biochemistry|October 11, 2022
The association between acid-base status and clinical outcome in critically ill COVID-19 patients admitted to intensive care unit with an emphasis on high anion gap metabolic acidosisAnnalise E Zemlin, Lovemore N Sigwadhi, Owen J Wiese, et al.
Metabolic Brain Disease|March 12, 2021
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS casesSusan J van Rensburg, Coenraad Hattingh, Clint Johannes, et al.
IJID Regions|November 7, 2022
Latent class analysis: an innovative approach for identification of clinical and laboratory markers of disease severity among COVID-19 patients admitted to the intensive care unitLovemore N Sigwadhi, Jacques L Tamuzi, Annalise E Zemlin, et al.
Pageof 11